NIH-funded research R15 grant

Investigating how a specific receptor affects nerve cell death in aging-related diseases.

Official title: The Role of the p75 Neurotrophin Receptor in Dopaminergic Neurodegeneration Induced by Oxidative Stress.

Funded at University of Alabama in Huntsville · NIH-10437963 · Data updated 2026-11-12

This study is looking at how a specific receptor in the brain might cause the death of important dopamine-producing cells, which is a big concern for people with Parkinson's disease, and it hopes to find new ways to protect these cells and improve treatment options for older adults.

More Oxidative Stress research and trials

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionUniversity of Alabama in Huntsville
NIH-funded
Lab location1 site (Huntsville, United States)
Project startSeptember 15, 2022
Project endApril 30, 2026
Funding year2022
Award (this year)$437,997
NIH project number1R15NS111413-01A1
Project IDNIH-10437963 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are older adults experiencing symptoms of neurodegenerative diseases, particularly those related to dopamine dysfunction.

Less likely to help

Patients who are not elderly or do not have neurodegenerative conditions may not benefit from this research.

What this research studies

This research focuses on understanding the role of the p75 neurotrophin receptor in the death of dopamine-producing neurons, particularly in the context of neurodegenerative diseases like Parkinson's. The researchers will use cultured cells and animal models to explore how oxidative stress activates this receptor and leads to neuronal death. By uncovering the mechanisms involved, the study aims to identify potential new treatment strategies that could prevent or reduce neurodegeneration in older adults.

Why it matters

Potential benefit: If successful, this research could lead to novel therapies that slow down or prevent the progression of neurodegenerative diseases in the elderly.

How similar studies have gone: Previous research has shown promise in targeting neurotrophin receptors for neuroprotection, suggesting potential for success in this novel approach.

Where this research is happening

  • University of Alabama in Huntsville
    Huntsville, United States
    Active

Researchers

  • Principal investigator: Kraemer, Bradley R — University of Alabama in Huntsville
  • Study coordinator: Kraemer, Bradley R

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.